Annual Drug Patent Expirations for JENTADUETO+XR Jentadueto Xr is a drug marketed by Boehringer Ingelheim and is included in one […]
New patent expiration for Boehringer Ingelheim drug JENTADUETO XR Read Post »
Annual Drug Patent Expirations for BINOSTO Binosto is a drug marketed by Ascend Theraps Us and is included in one
New patent expiration for Ascend Theraps drug BINOSTO Read Post »
Annual Drug Patent Expirations for SUMAVEL+DOSEPRO Sumavel Dosepro is a drug marketed by Endo Ventures Ltd and is included in
New patent expiration for Endo Ventures drug SUMAVEL DOSEPRO Read Post »
SIGNIFOR LAR KIT (pasireotide pamoate) Recordati rare Patent: 8,822,637 Expiration: Aug 6, 2023 See More … For more information on
Drug Patent Expirations for the Week of August 6, 2023 Read Post »
Annual Drug Patent Expirations for ABILIFY+MAINTENA+KIT Abilify Maintena Kit is a drug marketed by Otsuka Pharm Co Ltd and is
New patent expiration for Otsuka Pharm drug ABILIFY MAINTENA KIT Read Post »
Annual Drug Patent Expirations for SIGNIFOR+LAR+KIT Signifor Lar Kit is a drug marketed by Recordati Rare and is included in
New patent expiration for Recordati Rare drug SIGNIFOR LAR KIT Read Post »
Annual Drug Patent Expirations for PATANASE Patanase is a drug marketed by Novartis and is included in one NDA. It
New patent expiration for Novartis drug PATANASE Read Post »
DEXILANT SOLUTAB (dexlansoprazole) Takeda pharms usa Patent: 6,664,276 Expiration: Jul 30, 2023 See More … For more information on how
Drug Patent Expirations for the Week of July 30, 2023 Read Post »
Annual Drug Patent Expirations for KOMBIGLYZE+XR Kombiglyze Xr is a drug marketed by Astrazeneca Ab and is included in one
New patent expiration for Astrazeneca Ab drug KOMBIGLYZE XR Read Post »
Get fresh news and insights, drug patent expirations & more…
